{"filing":{"accession_number":"0001193125-26-335157","cik":"0001501796","ticker":"AURA","company_name":"Aura Biosciences, Inc.","form":"8-K","filing_date":"2026-08-05","report_date":"2026-08-05","primary_document":"aura-20260805.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1501796/000119312526335157/aura-20260805.htm"},"events":[{"id":24759,"run_id":22446,"accession_number":"0001193125-26-335157","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"This is a clear disclosure of shareholder vote results from a Special Meeting of Stockholders held on August 5, 2026. The filing reports final voting tallies for two proposals: (1) approval of an amendment to increase authorized common shares from 150 million to 500 million, and (2) approval of Amendment No. 1 to the 2021 Stock Option and Incentive Plan. Both proposals passed. The increase in authorized shares is material as it affects the company's capital structure and dilution potential, and the stock plan amendment is material to executive compensation and equity allocation.","company_name":"Aura Biosciences, Inc.","ticker":"AURA","filing_date":"2026-08-05","form":"8-K","submitted_at":null,"items":[{"id":25424,"accession_number":"0001193125-26-335157","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This is a clear disclosure of shareholder vote results from a Special Meeting of Stockholders held on August 5, 2026. The filing reports final voting tallies for two proposals: (1) approval of an amendment to increase authorized common shares from 150 million to 500 million, and (2) approval of Amendment No. 1 to the 2021 Stock Option and Incentive Plan. Both proposals passed. The increase in authorized shares is material as it affects the company's capital structure and dilution potential, and the stock plan amendment is material to executive compensation and equity allocation.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-07T02:19:35.536687+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":25424,"accession_number":"0001193125-26-335157","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This is a clear disclosure of shareholder vote results from a Special Meeting of Stockholders held on August 5, 2026. The filing reports final voting tallies for two proposals: (1) approval of an amendment to increase authorized common shares from 150 million to 500 million, and (2) approval of Amendment No. 1 to the 2021 Stock Option and Incentive Plan. Both proposals passed. The increase in authorized shares is material as it affects the company's capital structure and dilution potential, and the stock plan amendment is material to executive compensation and equity allocation.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-07T02:19:35.536687+00:00","company_name":"Aura Biosciences, Inc.","ticker":"AURA","filing_date":"2026-08-05"}]}